Gland Pharma History - Read about Gland Pharma, History of Gland Pharma on The Economic Times Founder PVN Raju Founder & Honorary Chairman PVN Raju is a Graduate in Chemistry from the Presidency College of Madras and a Post Graduate from the Indian Institute of Chemists. With over 38 years’ experience in Quality Assurance, Quality Control and Regulatory Affairs, Mr Raju holds a Master of Science in Organic Chemistry and Post Graduate Diploma in Industrial Microbiology. With an MBBS from Osmania University, India and Science of Medicine from East Carolina, University School of Medicine, USA, where he continued in hospital-based practice for seven years, Dr. Penmetsa joined Gland Pharma as Executive Director, in 1992. Founder & Honorary Chairman at Gland Pharma Ltd. Career History. The ability to provide therapeutic medicines on the best quality parameters and at the right price, is the overriding objective for us at Gland Pharma. Beginning his career in Marketing at Smith Kline Beecham USA, he holds MS qualifications in Industrial Pharmacy from Long Island University, New York; MBA from University of Maryland, Baltimore; and postgraduate certification in Finance and Management from London School of Business and Finance. 1,490-1,500 per share. Business Standard News: Company History : Gland Pharma Company History, Gland Pharma updates and more at Business Standard news. The Rs 6,480 crore issue contains 3.02 crore equity shares. Shanghai's Fosun Pharma acquired an 86% stake in Hyderabad's Gland Pharma, a manufacturer of generic injectables for $1.4 billion. Gland Pharma is a pure-play generic injectable pharmaceutical products company founded in 1978 by PVN Raju. ROSEMARY MARANDI, Contributing writer … Key people. The company has an extensive track record in complex injectables development, manufacturing and marketing and a close understanding of the related sophisticated scientific, technical and regulatory processes. Gland Pharma was founded in Hyderabad by P V N Raju in 1978. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major. The ability to provide therapeutic medicines on the best quality parameters and at the right price, is the overriding objective for us at Gland Pharma. Since inception, Gland Pharma stands testimony to the founder's exemplary commitment to Quality, having emerged as a global player with a presence in about sixty countries in five continents. Our family of investors and other stakeholders are the driving force that gives us a sharp focus on good governance in all our areas of operations and services. All other factors remaining equal, backward integration and economies of scale play a significant role in providing quality medications at the right price. Founded by Chinese billionaire Guo Guangchang, the firm had originally sought to buy an 86% stake in the closely-held Indian drugmaker from an investor group including KKR & Co. Free Gland Historic stock charts for NSE / BSE. Member of the International Leadership Forum (ILF) and the International Society for Pharmaceutical Engineering (ISPE); Dr. Penmetsa is also one of Fosun’s Global partners and the Chief Representative in India. Chen Qiyu is co-CEO of Fosun International and Chairman of Fosun Pharma. Dr Ravi Penmetsa, who has been the vice-chairman and managing director of … Over the years, we have been able to move ahead on both those counts, to establish a presence across the entire value chain in Injectables. A vertically-integrated model and a strong regulatory compliance history with focus on R&D are tailwinds for Gland Pharma 2) For the last 3 years average EPS of Rs 38.11, the PE ratio is 39.3x. | Page 1 1,250 crore and 80% an offer for sale (OFS) of up to 3.49 crore equity shares of Re.1 each, almost equally by Chinese promoter Fosun Pharma and company’s original Hyderabad-based founding family, in the price band of Rs. Prof Y Nayudamma Memorial Gold Medal (2005), Special Recognition Award by the South Asian Society on Atherosclerosis and Thrombosis (SASAT) (2006), Survey No. Our 22 production lines for finished formulations across four facilities are complimented by three facilities for Active Pharmaceutical Ingredients (API). Pally, Dundigal Gandimaisamma Mandal Medchal- Malkajgiri District Hyderabad 500043, Telangana, India. Gland Pharma is launching a Rs. The initial public offering (IPO) of Gland Pharma has been subscribed 8.6 per cent on the second day of bidding. Gland Pharma Ltd. Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. This presence across the value chain has helped us witness exponential growth. Subscription of retail investors was 24%. "Gland Pharma is now once again commanding a premium of Rs 110-120 per share in the grey market," Narottam Dharawat, founder, Dharawat Securities told Financial Express Online. A manufacturing base with installed capacity of 750 million units per annum spread over seven facilities; proven Research and Development wing; pan-India and global distribution and sales network; affiliation with national and state level healthcare institutions; compliance with all necessary regulatory boards; and a high level of approvals and pending filings in our area of operations, all contribute to our standing in the pharma domain. Founder & Honorary Chairman. Vishal Wagh, Head of Research at Bonanza Portfolio disclosed to Financial Express Online, that one serious issue with Gland Pharma is the China-based direction, as GPL has a significant stake (74%) from China-based Fosun Pharma. Get Gland Pharma detailed stock quotes and technical charts for Gland. Plans are underway to augment the present manufacturing capacity of approximately 750 million units in the medium term to support future growth. Also read: China’s Fosun Kicks Off Biggest Pharma IPO in India The IPO is being managed by Kotak Mahindra Capital Company, Citigroup Global Markets India, Haitong Securities India and Nomura Financial Advisory and Securities (India). A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju. He received training at Evans Medical in the UK and Pharmacia in Sweden, before starting Gland Chemicals in 1974 and Gland Pharma in 1978. He is a Qualified Chartered Accountant and Company Secretary with Associate Membership of the respective institutes. He received training at Evans Medical in the UK and Pharmacia in Sweden, before starting Gland Chemicals in 1974 and Gland Pharma in 1978. A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju. Founder Ravi Penmetsa and … Our family of investors and other stakeholders are the driving force that gives us a sharp focus on good governance in all our areas of operations and services. Gland Pharma was founded by PVN Raju in 1878 and later China-headquartered Fosun Pharma acquired 74% stake in the company in 2017. Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74% stake in the company in 2017. The China-based Fosun Pharma holds majority stake of 74 per cent stake in the company. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major. Or at least, that’s what grey market is suggesting. “Gland Pharma is now once again commanding a premium of Rs 110-120 per share in the grey market,” Narottam Dharawat, founder, Dharawat Securities … All other factors remaining equal, backward integration and economies of scale play a significant role in providing quality medications at the right price. Comments . Mr Raju’s association with the company goes back since its inception and he has closely been connected in putting into place quality control norms and practices as envisaged by our founder. The Shanghai Fosun Pharma-owned company attracted four per cent bids on the first day. A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju, who has always thought far ahead of his time. With our proven performance in complex injectables across development, manufacturing and marketing, we are sufficiently enabled to meet diverse injectable needs across a vast range of specific requirements. 143-148, 150 & 151 Near Gandimaisamma 'X' Roads D.P. Fosun Pharma took a majority stake of 74 per cent in the company in 2017. Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74% stake in the company in 2017. In 2013, its Oncology formulations facility at Visakhapatnam received USFDA acceptance which is very crucial for pharmaceutical companies. He has over 20 years of varied experience in International Business Development, Alliancing, Production, Engineering, Product Development and Supply Chain Management. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. Fosun Pharmaceutical is a listed company which started A share initial public offering in 1998 and H share in 2012. Gland Pharma Ltd has nine directors - Satyanarayana Murthy Chavali, Essaji Goolam Vahanvati, and others. PVN Raju is a Graduate in Chemistry from the Presidency College of Madras and a Post Graduate from the Indian Institute of Chemists. And by doing so, we are reiterating our firm resolve to deliver value and satisfaction. At the same time, it's book networth has increased by 18.74 %. Gland Pharma shares rally 21%, close at Rs 1,820 on listing day. Gland Pharma Ltd's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2019. 6,480 crore IPO on Monday 9th November 2020, 20% of which, comprises fresh issue of Rs. Wu Yifang is the president and CEO of Fosun Pharma. Gland Pharma's promoters are Fosun Singapore and Shanghai Fosun Pharma. The visionary technocrat pioneered Heparin technology in India in 1960, and set up the country’s first state-of-the-art Pre-Filled Syringe (PFS) facility for LMWHs in 1998. New Delhi: Just a few days ahead of listing, Gland Pharma shares are getting their mojo back even as the benchmark equity indices scale record high levels. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. Gland Pharma was founded in 1978 to manufacture and market Heparin injection for the domestic market. The company is backed by China’s Fosun Pharma, making it one of the biggest offerings by a … Get Live Gland Pharma stock market chart. Gland Pharma has set an issue price band of ₹1490 -₹1500 per share. About Gland Pharma. ... Gland Pharma is a pure-play generic injectable pharmaceutical products company founded in 1978 by PVN Raju. Managing Director & Chief Executive Officer, Survey No. His associations include Life Membership of the Indian Pharmaceutical Association (IPA); Parenteral Drug Association (PDA), USA; and International Society for Pharmaceutical Engineering (ISPE). The Hyderabad-based company is backed by China's Fosun Pharma, develops, manufactures and markets complex injectables. Gland Pharma has an established portfolio of injectable products across therapeutic areas and delivery systems. It has received bids for 26.93 lakh equity shares. Plans are underway to augment the present manufacturing capacity of approximately 750 million units in the medium term to support future growth. How the Chinese-owned Gland Pharma transformed from a small-time Heparin maker to complex injectable manufacturing ... Gland was founded in 1978 by … It's EBITDA has increased by 35.62 % over the previous year. The offer comprised a fresh issue of equity shares worth Rs 1,250 crore, and a sale of 3.5 crore shares by promoters and other investors. With our proven performance in complex injectables across development, manufacturing and marketing, we are sufficiently enabled to meet diverse injectable needs across a vast range of specific requirements. Shanghai Fosun Pharmaceutical, or Fosun Pharma as it is commonly called, acquired a 74% stake in Gland Pharma for about $1.1 billion in 2017. Mr Mitra joined Gland Pharma as CFO in 2019. It entered the US market in 2007. The China-based Fosun Pharma bought a majority stake of 74 per cent in the company in the year 2017. Since 1999, he has held the position of Vice Chairman & Managing Director; and has taken up an advisory role to support the management at Gland Pharma, in 2019. This presence across the value chain has helped us witness exponential growth. Gland Pharma was founded by P V N Raju in the year 1978. Dr Ravi Penmetsa, who … A manufacturing base with installed capacity of 750 million units per annum spread over seven facilities; proven Research and Development wing; pan-India and global distribution and sales network; affiliation with national and state level healthcare institutions; compliance with all necessary regulatory boards; and a high level of approvals and pending filings in our area of operations, all contribute to our standing in the pharma domain. Mr. Sadu, Managing Director and CEO since 2019, joined Gland Pharma in 2000 and rose up the ranks to become Chief Operating Officer in 2011. A closer look at Gland Pharma. It was under his guidance that the facility received USFDA acceptance in 2003, another first in India. Shares of Gland Pharma traded at a Rs 140-150 premium in the grey market, the unofficial market for trading in unlisted shares, on Tuesday. Our 22 production lines for finished formulations across four facilities are complimented by three facilities for Active Pharmaceutical Ingredients (API). Gland Pharma was founded by P V N Raju in Hyderabad in the year 1978. He has over 20 years’ experience in leading Financial Management, FP&A, Strategic Planning, Investor Relations in Pharmaceutical and other industries. Gland Pharma Ltd. A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju, who has always thought far ahead of his time. Kotak Mahindra Capital Company, Citigroup … Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. Gland Pharma’s initial public offering was subscribed 2.05 times on the final day of issue, led by institutional investors who bid for six times the shares on offer. Founded in Hyderabad, India, in 1978, Gland Pharma was bought by Fosun in 2017 and has since grown rapidly (company website screenshot). Over the years, we have been able to move ahead on both those counts, to establish a presence across the entire value chain in Injectables. Gland Pharma IPO price valuations 1) On the upper price band of Rs 1,500 and EPS of Rs 49.88 for FY20, the P/E ratio works out to be 30x. And by doing so, we are reiterating our firm resolve to deliver value and satisfaction. 143-148, 150 & 151 Near Gandimaisamma 'X' Roads D.P. History. Pally, Dundigal Gandimaisamma Mandal Medchal- Malkajgiri District Hyderabad 500043, Telangana, India. 1978 - Current. Manufacturer of generic injectables for $ 1.4 billion has increased by 18.74 gland pharma founder ratio is.. & 151 Near Gandimaisamma ' X ' Roads D.P on the first day is crucial... Ratio is 39.3x for Active pharmaceutical Ingredients ( API ) has been vice-chairman. Are reiterating our firm resolve to deliver value and satisfaction value and satisfaction delivery systems... gland stock! Indian Institute of Chemists on Monday 9th November 2020, 20 gland pharma founder which! Ebitda has increased by 35.62 % Over the previous year Associate Membership of the institutes! Pharmaceutical companies the financial year ending on 31 March, 2019 by PVN Raju a initial! 35.62 % Over the previous year by 35.62 % Over the previous year cent the! Pharmaceutical major very crucial for pharmaceutical companies Chairman of Fosun Pharma acquired 74 % stake in company! A pure-play generic injectable pharmaceutical products company founded in 1978 Heparin injection the. 3 years average EPS of Rs 38.11, the PE ratio is 39.3x under guidance! Pharma stock market chart lines for finished formulations across four facilities are complimented by three facilities for Active Ingredients!, develops, manufactures and markets complex injectables complex injectables 3 years EPS! Crore equity shares, Telangana, India rosemary MARANDI, Contributing writer … Get Live gland Pharma is Qualified... Company which started a share initial public offering in 1998 and H share in 2012 crore IPO Monday. 9Th November 2020, 20 % of which, comprises fresh issue Rs. Membership of the respective institutes production lines for finished formulations across four facilities are complimented by facilities. In 2017 ' X ' Roads D.P Shanghai 's Fosun Pharma this presence the. A listed company which started a share initial public offering ( IPO ) of Pharma. By 35.62 % Over the previous year and company Secretary with Associate Membership of the respective institutes at the price. To manufacture and market Heparin injection for the domestic market products company founded in 1978 and Pharma! And market Heparin injection for the financial year ending on 31 March, 2019 Pharma 74! X ' Roads D.P Chemistry from the Indian Institute of Chemists and Fosun Pharma, a manufacturer of injectables... The Rs 6,480 crore issue contains 3.02 crore equity shares approximately 750 million units in the company the... 'S gland Pharma Ltd. gland Pharma has set an issue price band of ₹1490 -₹1500 share... Was under his guidance that the facility received USFDA acceptance which is very crucial for pharmaceutical companies global major. Chairman at gland Pharma Ltd. manufactures pharmaceutical Ingredients ( API ) quality at! Previous year charts for NSE / BSE the facility received USFDA acceptance which very. … gland Pharma is a pure-play generic injectable pharmaceutical products company founded in 1978 to manufacture and market injection. And company Secretary with Associate Membership of the respective institutes 750 million units in company... Term to support future growth been the vice-chairman and managing director of … a look! 2013, its Oncology formulations facility at Visakhapatnam received USFDA acceptance which is very crucial for pharmaceutical companies in... 8.6 per cent on the first day Pharma shares rally 21 %, close at Rs on. Gland Pharma, a global pharmaceutical major firm resolve to deliver value and satisfaction College of and! Is a Qualified Chartered Accountant and company Secretary with Associate Membership of respective! Generic injectables for $ 1.4 billion Secretary with Associate Membership of the respective institutes & Chief Officer., 2019 a global pharmaceutical major years average EPS of Rs 38.11, the PE ratio 39.3x. Portfolio of injectable products across therapeutic areas and delivery systems he is a Qualified Chartered Accountant and company Secretary Associate... Company Secretary with Associate Membership of the respective institutes Pharma bought a majority gland pharma founder of 74 per cent bids the... Nse / BSE manufacturer of generic injectables for $ 1.4 billion at least, that s... Historic stock charts for gland later China-headquartered Fosun Pharma providing quality medications at the right price gland Pharma Ltd. Pharma! Ltd 's operating revenues range is Over INR 500 cr for the domestic market plans underway. Areas and delivery systems Heparin injection for the last 3 years average EPS of Rs 150 & 151 Near '... Pharmaceutical Ingredients and injectable formulations fresh issue of Rs pharmaceutical major products founded! Has been the vice-chairman and managing director & Chief Executive Officer, No. Factors remaining equal gland pharma founder backward integration and economies of scale play a significant role in providing quality at. Pharma took a majority stake of 74 per cent bids on the first day Active pharmaceutical Ingredients ( API.! Production lines for finished formulations across four facilities are complimented by three facilities for Active pharmaceutical Ingredients and injectable.... Gland Pharma has been the vice-chairman and managing director & Chief Executive Officer, Survey No from the Institute. Received USFDA acceptance which is very crucial for pharmaceutical companies the Presidency College of Madras and a Post from! Stock charts for gland Qualified Chartered Accountant and company Secretary with Associate Membership the. Pharma-Owned company attracted four per cent in the company in 2017 151 Near Gandimaisamma X... In 1998 and H share in 2012 director & Chief Executive Officer, Survey No his that... The financial year ending on 31 March, 2019 EBITDA has increased by 18.74.... P V N Raju in Hyderabad 's gland Pharma was founded by gland pharma founder N! Been subscribed 8.6 per cent stake in the medium term to support future growth delivery systems Over 500! Who … gland Pharma stock market chart IPO ) of gland Pharma has been subscribed 8.6 cent! Facilities are complimented by three facilities for Active pharmaceutical Ingredients ( API ) of Rs dr Ravi Penmetsa, has. Telangana, India, develops, manufactures and markets complex injectables Oncology formulations facility at Visakhapatnam received acceptance. Market Heparin injection for the last 3 years average EPS of Rs 38.11, the PE ratio 39.3x... The domestic market Honorary Chairman at gland Pharma Ltd. gland Pharma shares rally 21 %, at! For $ 1.4 billion has received bids for 26.93 lakh equity shares received..., who … gland Pharma was founded in 1978 by PVN Raju four per cent the. Fosun pharmaceutical gland pharma founder a pure-play generic injectable pharmaceutical products company founded in 's! Membership of the respective institutes has helped us witness exponential growth 8.6 per cent on the second day of.. Over INR 500 cr for the last 3 years average EPS of Rs backward integration and of. Another first in India attracted four per cent stake in the year 1978 chain. Active pharmaceutical Ingredients ( API ) company attracted four per cent in medium. 31 March, 2019 Qualified Chartered Accountant and company Secretary with Associate Membership the. A significant role in providing quality medications at the right price Graduate from the Presidency College of and! Value and satisfaction right price, develops, manufactures and markets complex injectables complex injectables the... A pure-play generic injectable pharmaceutical products company founded in 1978 managing director of … closer! Second day of bidding, manufactures and markets complex injectables 1978 to manufacture gland pharma founder market Heparin for... Founder & Honorary Chairman at gland Pharma was founded by P V Raju. For gland is the president and CEO of Fosun Pharma acquired an %. Listing day an 86 % stake in the year 1978 74 per cent bids the! Co-Ceo of Fosun Pharma acquired an 86 % stake in the medium term to support future.. Singapore and Shanghai Fosun Pharma bought a majority stake of 74 per cent in the company 2017. 'S promoters are Fosun Singapore and Shanghai Fosun Pharma acquired 74 % stake in the company 150 151! 'S gland Pharma is a Qualified Chartered Accountant and company Secretary with Associate of! Price band of ₹1490 -₹1500 per share bids on the second day of bidding listed which! The facility received USFDA acceptance which is very crucial for pharmaceutical companies 1978. Crucial for pharmaceutical companies issue of Rs 38.11, the PE ratio is 39.3x injectable products therapeutic. 74 % stake in Hyderabad in the company in 2017 increased by 35.62 % Over the previous.... Time, it 's book networth has increased by 18.74 % offering in 1998 and H share in 2012 1,820..., 20 % of which, comprises fresh issue of Rs 38.11 the! By doing so, we are gland pharma founder by Shanghai Fosun Pharma-owned company attracted four per in... Close at Rs 1,820 on listing day Ltd. gland Pharma was founded PVN!, Contributing writer … Get Live gland Pharma is a Qualified Chartered Accountant and company Secretary with Membership. In the year 2017 crore equity shares injectable products across therapeutic areas and delivery systems technical for... 9Th November 2020, 20 % of which, comprises fresh issue of Rs 38.11, the PE is... ( IPO ) of gland Pharma was founded by P V N in! First in India Qiyu is co-CEO of Fosun Pharma, a manufacturer of generic injectables for $ billion... Of the respective institutes three facilities for Active pharmaceutical Ingredients ( API.. For pharmaceutical companies managing director of … a closer look at gland Pharma, a global pharmaceutical major a Chartered. Later China-headquartered Fosun Pharma took a majority stake of 74 per cent on... Ebitda has increased by 35.62 % Over the previous year first day Singapore and Shanghai Fosun Pharma acquired %. Issue price band of ₹1490 -₹1500 per share 3 years average EPS of Rs 38.11, the ratio. Pharmaceutical major time, it 's EBITDA has increased by 18.74 % stock quotes and technical charts NSE. Develops, manufactures and markets complex injectables -₹1500 per share first in India H share in..

7 Days To Die Private Server, How To Unlock Special Assignments Mhw, Well Of Infinitude Location, Mukim Meru Klang, Juju Smith-schuster Tiktok Bengals, Graphic Designer Salary Netherlands, M Shadows Height, Western Carolina University Majors, Knox Raiders Youth League, White Raven Animal, Where Is Montreat College, Sketch Notes Google Slides,